AI assistant
Sending…
Minerva Neurosciences, Inc. — Director's Dealing 2018
Aug 2, 2018
35086_dirs_2018-08-02_9c04d00a-ad21-4d65-862a-99d2f748e847.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2018-08-01
Reporting Person: DOYLE WILLIAM F (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-08-01 | Stock Option (Right to Buy) | $7.95 | A | 20000 | Acquired | 2028-08-01 | Common Stock (20000) | Direct |
Footnotes
F1: This option shall vest quarterly over one year commencing on August 1, 2018.
More from Minerva Neurosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Capital/Financing Update
2026
May 27
Share Issue/Capital Change
2026
May 27
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Feb 17